SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and massive trading volume following a record-breaking earnings report that showed significant revenue growth and improved guidance. Investors are actively debating the potential for a short squeeze, given the stock's high short interest, while community discussions remain sharply divided between those anticipating a major breakout and those warning of a potential pump-and-dump scenario.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending after reporting record quarterly revenue that significantly exceeded analyst expectations, driven by strong Amtagvi demand and improved manufacturing margins. The community is actively discussing the company's upward trajectory, potential analyst upgrades, and the prospect of a short squeeze as the business reaches a fundamental inflection point.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors debate the impact of an unconfirmed short position reportedly opened by Michael Burry, which has triggered volatility and intense speculation regarding the firm's AI infrastructure fundamentals. Amidst these rumors, the community remains sharply divided between those bracing for a pullback and bulls who view the stock's recent price swings as a shakeout ahead of highly anticipated earnings.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing significant volatility and negative investor sentiment heading into its earnings report, driven by persistent selling pressure and ongoing community comparisons to better-performing ad-tech peers. Shareholders are closely watching for signs of growth or a potential strategic pivot, while short-interest levels and the stock's recent underperformance relative to the broader market remain central points of debate.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is facing significant downward pressure as investors react to a dual miss on top and bottom-line earnings and a lack of clear forward guidance. The community is sharply divided, with some investors liquidating positions due to fading confidence in core brand sales, while others view the sell-off as an irrational overreaction and are aggressively adding to their holdings in anticipation of a long-term turnaround.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares experienced a sharp pullback after reporting a slight revenue miss and softer-than-expected guidance, sparking intense debate among investors over whether the sell-off is an overreaction to minor quarterly fluctuations. While some market participants are taking advantage of the dip to accumulate shares due to strong underlying profitability and recent legal clarity, others remain cautious about potential deceleration in the company's long-term growth trajectory.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors focus on the upcoming earnings call, specifically seeking clarity on the clinical status of the proprietary COVID-19-Influenza Combination vaccine and the commercial trajectory of the Matrix-M adjuvant platform. Community discussion is polarized between frustration over the lack of near-term partnership announcements and bullish conviction in the long-term value of the company's vaccine technology.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending as the stock breaks through significant multi-year resistance, driven by strong quarterly earnings, upward guidance, and positive institutional sentiment following insider purchasing. Investors are actively debating whether this momentum can sustain a run toward the $40 level, with many viewing the current price action as a long-awaited fundamental re-rating for the health-tech platform.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is trending due to heightened investor sensitivity surrounding its high valuation and recent volatility, compounded by concerns over insider selling and broad weakness in the software sector. Community members are actively debating the company's long-term growth as a platform leader versus its current margin pressure, with many participants expressing frustration over the stock's significant pullbacks from recent highs.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing high volatility as investors weigh the company's aggressive expansion strategy and strong same-store sales growth against concerns regarding elevated valuations and margin pressure from rising operating costs. The community is actively debating the stock's long-term growth potential versus its high price-to-earnings multiple, with many traders closely monitoring post-earnings price action for signs of a sustained breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cocrystal Pharma Names James Sapirstein CEO, Stock Up In Pre-market

(RTTNews) - Cocrystal Pharma, Inc. (COCP) on Wednesday announced that it has appointed James Sapirstein chief executive officer, effective immediately, replacing co-chief executives Sam Lee and Jim Martin...

Why Cocrystal Pharma Shares Are Cooling Off Monday?

COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after receiving FDA Fast Track designation for CDI-988.read more...

Top Biotech Stocks To Follow Today - April 4th

Vertex Pharmaceuticals, Danaher, United Therapeutics, argenex, Moderna, Cocrystal Pharma, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results

US stocks fall, Dow drops over 50 points, real estate shares rise, Acuity Inc. shares decline, Sky Quarry Inc. and Cocrystal Pharma Inc. shares increase.read more...

Energy Crunch Sparks Sector Rally and Hidden Players Stepping into the Spotlight

A powerful convergence of global energy disruption and emerging technology catalysts is reshaping pockets of the market, with select small-cap names ready to make moves. $SKYQ, $XERI, $KBLB, $TGNT, $BDRX, $COCP

Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988

Cocrystal Pharma Inc. (NASDAQ:COCP) shares are trading higher Thursday after it received Fast Track designation from the FDA for its CDI-988.read more...

COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment?

Equity

Cocrystal stated that the Fast Track designation for CDI-988 enables accelerated development and expedited regulatory review.

Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Acquires 50,000 Shares

Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost purchased 50,000 shares of Cocrystal Pharma stock in a transaction that occurred on Friday, February 6th. The...

Phillip Md Et Al Frost Acquires 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock

Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost bought 50,000 shares of the company's stock in a transaction on Wednesday, December 31st. The shares were...

Cocrystal Pharma (NASDAQ:COCP) Director Phillip Md Et Al Frost Buys 20,000 Shares

Cocrystal Pharma, Inc. (NASDAQ:COCP - Get Free Report) Director Phillip Md Et Al Frost bought 20,000 shares of the firm's stock in a transaction dated Tuesday, December 30th. The stock was acquired...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs. The company was founded in 2008 and is headquartered in Bothell, WA.

Cocrystal Pharma Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

COCPCocrystal Pharma Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest COCP News